This two-decade surveillance revealed complex, species-specific antimicrobial resistance patterns. The high rate of FQ resistance in E. coli, despite a recent plateau, underscores the importance of incorporating local susceptibility data to guide empirical antibiotic selection. Continuous, facility-level surveillance is essential for effective antimicrobial stewardship and for optimizing patient treatment in an era of evolving resistance.
Takebe et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: